Dr. Shwetha Seetharam

• MBBS
• MD – General Medicine
• DM – Medical Oncology / Haematology

• Advanced training in cancer therapeutics and supportive oncology
• Exposure to state-of-the-art systemic therapies and personalised cancer care

• Registered with the medical regulatory authorities in India
• Member of national and international oncology professional organisations

• Breast cancer
• Lung cancer
• Gastrointestinal cancers
• Haematological malignancies (leukaemia, lymphoma, myeloma)
• Rare and complex tumour types

• Adult oncology
• Haematological cancer management
• Targeted therapy and immunotherapy
• Palliative and supportive care

• Chemotherapy and regimen planning
• Targeted therapy and immunotherapy
• Management of treatment-related complications
• Bone marrow evaluation and support
• Long-term survivorship management

Current Hospital Affiliation

• Consultant Medical Oncologist & Haematologist, Aster Medcity, Kochi, India
  

Past Hospital Affiliations

• Consultant roles at tertiary cancer care centres in India
• Experience in high-volume oncology units managing complex cancer cases

Academic & Research Roles

• Contributes to clinical tumour boards and multidisciplinary case reviews
• Participates in oncology CME programmes and educational workshops

Key Achievements & Contributions

• Extensive experience managing both prevalent and rare cancers
• Recognised for evidence-based treatment planning and compassionate care
• Focuses on patient education and long-term follow-up

Recognitions & Honors

• Acknowledged by colleagues and patients for clinical competence and empathetic communication

• Published Papers in Medical Journals

Dr Shwetha Seetharam has been involved in clinical research and scholarly discussions related to oncology practice, targeted therapies and treatment outcomes.

Seetharam S, Thankamony P, Gopakumar KG, Nair RA, Jacob PM, Jagathnath Krishna KM, Rajeswari B, Nair M, Guruprasad CS, Prasanth VR. Outcomes of pediatric mixed phenotype acute leukaemia treated with lymphoid-directed therapy: Analysis of an institutional series from India. Pediatr Hematol Oncol. 2021 May;38(4):358-366. doi: 10.1080/08880018.2020.1871453. Epub 2021 Feb 26. PMID: 33635170.https://www.tandfonline.com/eprint/BYSN3BAU5YUYTMNDVHQ3/full?target=10.1080/08880018.2020.1871453 

Seetharam S, Thankamony P, Jacob PM, Nair RA. Precursor B-cell lymphoblastic lymphoma of bone in children: A close mimicker of Ewing's sarcoma. Indian J Med Paediatr Oncol 2018;39:385-7. 

Boddu D, Thankamony P, Guruprasad CS, Nair M, Rajeswari B, Seetharam S. Effect of imatinib on growth in children with chronic myeloid leukaemia. Pediatr Hematol Oncol. 2019 May;36(4):189-197. doi: 10.1080/08880018.2019.1610119. Epub 2019 Jul 12. PMID: 31298597.

Seetharam S, Thankamony P, Gopakumar KG, Krishna KMJ. Higher incidence of syndrome of inappropriate antidiuretic hormone secretion during induction chemotherapy of acute lymphoblastic leukaemia in indian children. Indian J Cancer. 2019 Oct-Dec;56(4):320-324. doi: 10.4103/ijc.IJC_737_18. PMID: 31607700.

Ongoing Clinical Trials Participation

• Involved in institutional clinical research where applicable

• Dr Shwetha has successfully guided patients through complex cancer treatment pathways, ensuring both therapeutic efficacy and quality of life.

Patient Testimonials

• Guiding Patients Through Complex Cancer Journeys
  Patients and families frequently share how Dr Shwetha Seetharam provides clarity and reassurance at every stage of cancer care. Testimonials often highlight her ability to explain diagnoses, treatment options, and expected outcomes in a calm, compassionate manner, helping patients feel informed and confident while navigating emotionally challenging decisions.
• Personalised and Effective Cancer Treatment
  Individuals undergoing chemotherapy, targeted therapy, or immunotherapy under Dr Shwetha’s care commonly report well-structured treatment plans tailored to their specific cancer type and overall health. Feedback reflects appreciation for her evidence-based approach, close monitoring of side effects, and timely adjustments to therapy, which together contribute to improved treatment tolerance and positive clinical outcomes.
• Empathy, Support, and Long-Term Care
  Patients consistently commend Dr Shwetha for her empathetic bedside manner and continued support beyond active treatment. Many testimonials mention her accessibility, patience in addressing concerns, and focus on quality of life, survivorship, and follow-up care. Families often describe her as a trusted guide who combines clinical expertise with genuine compassion throughout the cancer care journey.

• Patient-Centred Care
  Dr Shwetha believes that oncology care should be holistic, collaborative and transparent, involving patients and families in every step of decision-making while aligning treatment choices with patient priorities.
• Technology & Innovation
  She incorporates evidence-based systemic therapies, advanced imaging support, and evolving targeted approaches to deliver precise, optimised cancer care.

*Costs may vary based on treatment complexity, drug protocols, hospital policies and individual patient requirements.
For a consultation fee or personalised cost

The Cancer Rounds team aids in:

• Professional interpreter services to ensure seamless communication: The Cancer Rounds team ensures that language is never a barrier to comprehending complicated medical procedures by offering qualified interpreters to help patients from other countries.
• Medical visa guidance and documentation support: Cancer Rounds provides complete assistance with local transportation, airline reservations, and medical visas. For families staying for lengthy treatments like transplants, we can help arrange long-term housing.
• Pre-treatment virtual consultations to review reports and discuss care plans: Before visiting India, families can schedule a video appointment with Dr Shwetha Seetharam via Cancer Rounds to go over medical reports and treatment choices.